Thomas Striepe - Sangui Biotech CEO and President and Executive Director
| SGBI Stock | USD 0 0.00 0.00% |
CEO
Mr. Thomas Striepe is Chief Executive Officer, Director of Sangui Biotech International Inc. He is Vice President Accounting and Controlling at Treukonzept Finance GmbH, Hamburg, Germany, a financial services company. Prior to joining Treukonezpt Finance GmbH in 2004, he held management positions in the accounting departments of several German and international corporations. He holds an MBA of Hamburg University. since 2008.
| Age | 61 |
| Tenure | 16 years |
| Professional Marks | MBA |
| Phone | 49 40 609 3120 |
| Web | https://www.sanguibiotech.com |
Sangui Biotech Management Efficiency
The company has return on total asset (ROA) of (0.6411) % which means that it has lost $0.6411 on every $100 spent on assets. This is way below average. Sangui Biotech's management efficiency ratios could be used to measure how well Sangui Biotech manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | CEO Age | ||
| Chintu RPh | Amneal Pharmaceuticals Class | 52 | |
| Robert Stewart | Amneal Pharmaceuticals Class | 50 | |
| Chirag Patel | Amneal Pharmaceuticals Class | 57 | |
| James Hall | Lifecore Biomedical | 61 | |
| Chintu Patel | Amneal Pharmaceuticals Class | 49 | |
Management Performance
| Return On Asset | -0.64 |
Sangui Biotech Inter Leadership Team
Elected by the shareholders, the Sangui Biotech's board of directors comprises two types of representatives: Sangui Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sangui. The board's role is to monitor Sangui Biotech's management team and ensure that shareholders' interests are well served. Sangui Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sangui Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hubertus Schmelz, Non-Executive Director | ||
| Thomas Striepe, CEO and President and Executive Director |
Sangui Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sangui Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.64 | |||
| Profit Margin | (1.27) % | |||
| Operating Margin | (1.50) % | |||
| Current Valuation | 1.68 M | |||
| Shares Outstanding | 209.9 M | |||
| Shares Owned By Insiders | 13.03 % | |||
| Price To Earning | (18.33) X | |||
| Price To Book | 46.44 X | |||
| Price To Sales | 10.09 X | |||
| Revenue | 69.19 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sangui Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sangui Biotech's short interest history, or implied volatility extrapolated from Sangui Biotech options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sangui Biotech International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Sangui Biotech Inter information on this page should be used as a complementary analysis to other Sangui Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Sangui Pink Sheet analysis
When running Sangui Biotech's price analysis, check to measure Sangui Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sangui Biotech is operating at the current time. Most of Sangui Biotech's value examination focuses on studying past and present price action to predict the probability of Sangui Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sangui Biotech's price. Additionally, you may evaluate how the addition of Sangui Biotech to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |